While most hospitals that suspend heart transplants do so because of poor performance, Jefferson decided to pause its program in February while it searched for new leadership. At the time, the health system said the suspension was necessary while Jefferson underwent a “significant redesign” and expansion of the heart transplant program.
The health system said Andrew J. Boyle, MD, a cardiologist who joined Jefferson in June from the Piedmont Heart Institute in Atlanta, will serve as medical director of heart failure. Howard Todd Massey, MD, will serve as director of surgical treatment of advanced heart failure.
The expansion of the program will be supported by the addition of “shared-care sites” at other hospitals that agree to refer transplant candidates to Jefferson, according to the report. Jefferson will seek shared-care arrangements with Newark, Del.-based Christiana Care, Paoli, Pa.-based Main Line Health and Danville, Pa.-based Geisinger Health System, according to the report.
More articles on hospitals and physician issues:
One-third of NPs, PAs plan to change jobs: Here is what they are looking for
Despite lack of funding, plans for Wisconsin College of Osteopathic Medicine persist
KCU to begin recruiting students for Joplin medical school
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
